Related by context. All words. (Click for frequent words.) 62 NS4B 62 genetic loci 61 ADAM# 61 epigenetic regulation 61 Corus CAD 60 S. maltophilia 60 ACV1 60 pathogenic mechanisms 60 biologies 60 underlying pathophysiology 60 oncogenesis 59 p#/CBP 59 genetic modifiers 59 HCV replication 59 Froguel 59 multiplex assay 59 underlying molecular mechanisms 59 nongenetic 59 biologic pathways 59 FGFs 58 mechanistic studies 58 genetically altered mouse 58 molecular abnormalities 58 antibody mediated 58 histone methylation 58 sickle cell hemoglobin 58 renal fibrosis 58 Lpathomab 58 nanobacteria 58 amyloid formation 58 cAMP signaling 58 chromosome aberrations 57 CALHM1 57 GPCR targets 57 inhibit metastasis 57 Personalised medicine 57 antiangiogenesis 57 Hedgehog inhibitor 57 Tarvacin Anti Viral 57 microcephalin 57 Pancreate ™ 57 ESBA# 57 Micro RNAs 57 siRNA therapeutics 57 motor neuron degeneration 57 ADAMTS# 57 NNR Therapeutics 57 Singh Manoux 57 molecular underpinnings 57 kinase inhibition 57 prognostic markers 57 myelin repair 57 p# inhibitor 57 carcinoid 57 metabolomic profiles 57 molecularly targeted therapies 57 beta1 integrin 57 metabonomics 57 biopsychosocial 57 small molecule activators 56 Six3 56 PKM2 56 Th2 responses 56 angiogenesis inhibition 56 JAK inhibitors 56 Nicholas Katsanis Ph.D. 56 Debinski 56 etiologic factors 56 oligonucleotide therapeutics 56 Lambris 56 preclinically 56 NITD# 56 amyloid cascade 56 pathogenetic 56 Hotamisligil 56 iPS derived 56 intracellular signal transduction 56 epigenetic mechanisms 56 peptide therapeutics 56 Viola Vaccarino 56 IGFBP2 56 airway remodeling 56 prognostic biomarkers 56 A3 adenosine receptor 56 neuropsychiatric diseases 56 SCD1 56 Theranostics 56 EGFR pathway 56 diagnostic biomarker 56 ADME properties 56 Karlseder 56 GBA mutations 56 Nanobodies ® 56 Aortic stenosis 56 neurexins 56 mGluR5 antagonist 56 Genetic variants 56 UHCMC 56 EGFR HER 56 Wnts 56 non coding RNA 55 intracellular bacteria 55 SIRT1 gene 55 biochemical abnormalities 55 aP2 55 stratifying patients 55 breast cancer subtypes 55 posttranslational modifications 55 antisense oligonucleotides 55 molecular mimicry 55 thiopurine 55 genomic variants 55 DNA methylation patterns 55 CXCL5 55 SLC#A# [002] 55 Genetic mutation 55 DNA demethylation 55 mtDNA mutations 55 GATA3 55 PGRN 55 Tony Wyss Coray 55 autistic enterocolitis 55 γ secretase 55 anti angiogenic therapy 55 Skordalakes 55 mechanistic insights 55 n cofilin 55 urokinase plasminogen activator 55 phenotypic expression 55 transdifferentiation 55 therapeutic monoclonal antibody 55 atherogenesis 55 lipoprotein metabolism 55 TMEM#B 55 Nanobody ® 55 cathepsins 55 epigenetic modification 55 diagnostic biomarkers 55 kidney urologic 55 MEF2A 55 CB2 receptor 55 chromosomal translocation 55 inhibit angiogenesis 55 primary cilia 55 Mipomersen 55 boron neutron capture 55 TLE3 55 anticoagulant reversing agent 55 protein homeostasis 55 susceptibility loci 55 NF kB pathway 55 Inhaled nitric oxide 55 vaccinology 55 periodontal infections 55 pathophysiological 55 podocyte 55 GATA4 55 genetic determinants 55 genetic locus 55 Dr. Karsenty 55 Htt 55 Genetic predisposition 55 retinoid X 55 pathophysiologic 55 histone deacetylases 55 clogged carotid artery 55 fatty acid synthase 55 cell signaling pathways 55 Sodroski 55 anti angiogenic drugs 55 immunoregulation 55 DNA rearrangements 55 hedgehog pathway 55 coagulation cascade 55 MAPK pathway 55 osteoclast 54 CDK inhibitors 54 pre malignant lesions 54 cellular reprogramming 54 Pier Paolo Pandolfi 54 nAChR 54 cAMP pathway 54 Dr. Rafii 54 vertebrate embryos 54 PEDF 54 molecular biomarkers 54 neurocognitive deficits 54 causative genes 54 radiographic outcomes 54 DLX5 54 SIgN 54 Kyrkanides 54 molecular determinants 54 PI3K inhibitors 54 engineered RAP peptides 54 TGF ß 54 IRF6 54 etiological 54 Tom Misteli 54 clinicopathological 54 KLF4 54 primary hyperparathyroidism 54 deacetylase inhibitors 54 type2 diabetes 54 genetic underpinnings 54 Cyclin D1 54 tumor suppressor protein 54 mitochondrial disorders 54 cardio metabolic diseases 54 RNA splicing 54 neurite outgrowth 54 protein misfolding diseases 54 MitoQ 54 Dr. Sosne 54 Lyme arthritis 54 COX2 54 pathophysiological mechanisms 54 narcolepsy cataplexy 54 OnDose TM 54 endophenotypes 54 Wnt signaling pathway 54 molecular pathway 54 Androgen receptor 54 samalizumab 54 plasma kallikrein 54 extramedullary 54 immunological mechanisms 54 genetic aberrations 54 apo E 54 mRNA decay 54 Prox1 54 validating biomarkers 54 Apobec3 54 C. pneumoniae 54 edifoligide 54 BMP4 54 Induced pluripotent stem cells 54 melanocortin receptor 54 atherosclerosis regression 54 prostate carcinogenesis 54 ALI ARDS 54 pleiotropic effects 54 epigenomics 54 multigenic 54 beta defensins 54 diagnosing ADHD 54 vertebral subluxation 54 BRAF inhibitor 54 receptor ligand 54 NV1FGF 54 druggable targets 54 Spiegelmer 54 epigenetic modifications 54 fibrotic disease 54 HCV protease inhibitors 54 parthenolide 54 euthymic patients 54 cathepsin K 54 protein misfolding 54 IGF IR 54 antisense RNA 54 chromatin structure 54 Treg cell 54 Kohwi Shigematsu 54 Iruela Arispe 54 abnormal glucose metabolism 54 adult neurogenesis 53 Massague 53 neurotransmitter receptor 53 arachidonic acid metabolism 53 eotaxin 53 C. neoformans 53 noncoding RNA 53 resolvins 53 epithelial mesenchymal 53 Matthew Meyerson 53 protein tyrosine kinase 53 systemic RNAi 53 neovascularisation 53 glycomics 53 pathophysiological processes 53 alexithymia 53 virulence genes 53 PPARγ 53 ependymomas 53 histone modifications 53 CBLC# 53 ERK2 53 neuroactive 53 neuropsychological impairments 53 Weimbs 53 arterial stiffening 53 vitamin D receptors 53 plexiform 53 nicotinic receptor 53 Christos Mantzoros 53 transfusion syndrome 53 tolevamer 53 genomic alterations 53 PARP inhibition 53 BIIR 53 synovial cells 53 transcriptomics 53 full thickness plication 53 alpha synuclein gene 53 Alpha synuclein 53 miR #a [002] 53 malaria parasite genome 53 genomewide association studies 53 Akt3 53 posttranslational modification 53 CENP E 53 UVB induced 53 chromosomal imbalance 53 JAK3 53 TGF β 53 enzymatic reactions 53 Tolamba 53 mycosis 53 chimeric protein 53 GCN2 53 neuronal dysfunction 53 immunoregulatory 53 Helicobacter 53 mechanistically 53 C EBP alpha 53 insoluble proteins 53 phospholipid membranes 53 TRPV4 53 Tlsty 53 silico prediction 53 stapled peptides 53 inhibiting mTOR 53 mucosal immunity 53 metabolic dysfunction 53 oncolytic viral 53 PET tracers 53 synapse formation 53 chitinase 53 allodynia 53 comorbid disorders 53 mGluR5 inhibition 53 synaptogenesis 53 VEGF receptor 53 BCL6 gene 53 5 hydroxymethylcytosine 53 familial clustering 53 mediated inhibition 53 pathophysiologic mechanism 53 aetiology 53 fungal genomes 53 missense mutations 53 multifactorial disease 53 mTOR inhibition 53 Autoimmune diseases 53 TNFα 53 GSK3 53 HER2 neu 53 intracellular signaling pathways 53 mechanistic insight 53 non pharmacological interventions 53 Giulio Maria Pasinetti 53 atherosclerotic lesions 53 inverse agonist 53 enzymology 53 iPSC 53 mTOR signaling pathway 53 RNAi therapeutic targeting 53 siRNA therapeutic 53 CXCR4 receptor 53 GPx 53 Olefsky 53 multicellularity 53 oncomodulin 53 Wnt proteins 53 myosin II 53 neurotrophic 53 aptamer therapeutics 53 beta globin gene 53 androgen signaling 53 epigenetic therapeutics 53 cardiomyocyte 52 small RNAs encoded 52 genetic susceptibilities 52 immunological responses 52 Angiocept 52 methylation markers 52 HDAC6 52 lymphangiogenesis 52 EBV infection 52 Monoclonal antibody 52 COX enzymes 52 anticancer therapeutics 52 Salk researchers 52 antagomirs 52 OMAPRO 52 beta lactamases 52 vaso occlusive crisis 52 Genetic profiling 52 microbiomes 52 Smoothened 52 hormonal abnormalities 52 USP# 52 Galectin 3 52 Marambaud 52 Wnt beta catenin 52 inhibit viral replication 52 biosynthetic pathway 52 Nod1 52 Dr. Bezprozvanny 52 #T# L1 52 lipid nanoparticle LNP 52 vascular disrupting agents 52 siRNA knockdown 52 adipokines 52 mechanistic explanation 52 molecular subtypes 52 galectin 52 transgenic mouse models 52 microdeletion 52 aetiological 52 vascular thrombosis 52 psychoneuroimmunology 52 Brd4 52 prostate cancer metastasis 52 NOD2 52 CEACAM1 52 QTinno TM 52 NR#A# 52 premalignant lesions 52 tumorigenicity 52 proteasome inhibition 52 podocytes 52 ZNF# 52 CYT# potent vascular disrupting 52 TG# [003] 52 neural degeneration 52 nestin expression 52 microRNA expression 52 subclinical disease 52 Cognitive impairment 52 CXCR7 52 noncoding RNAs 52 neuropsychiatric disorder 52 orthomolecular medicine 52 Macklis 52 undiagnosed celiac disease 52 prodynorphin 52 membrane fusion 52 Tarvacin TM 52 obesity insulin resistance 52 variant angina 52 putative biomarkers 52 HMG CoA reductase 52 intercellular signaling 52 sRNA 52 telomere biology 52 somatoform disorders 52 interferon beta therapy 52 Affibody 52 antiphospholipid antibodies 52 neuropilin 52 microRNAs miRNAs 52 Zafgen 52 oligomerization 52 microRNA biomarkers 52 Fc receptor 52 triterpenoids 52 osteopontin OPN 52 amyloid toxicity 52 immunopathology 52 thrombophilia 52 Curaxin 52 biomedically 52 Dr. Rivella 52 neurobiological mechanisms 52 Alessandro Riva 52 hedgehog signaling 52 Wound healing 52 ANGPTL4 52 genomic variation 52 alpha7 52 topoisomerases 52 VIPR2 52 infantile hemangioma 52 Dr. Von Hoff 52 costimulation 52 PDGF receptor 52 canagliflozin 52 urate oxidase 52 autistic regression 52 immatics 52 peroxisome 52 neuroepithelial cells 52 γδ T cells 52 AAGP ™ 52 melanocortin receptors 52 neural progenitor 52 biologic plausibility 52 sclerostin 52 potent inhibitors 51 dedifferentiation 51 gastrulation 51 pleiotropy 51 bacterial enzyme 51 5 methylcytosine 51 JCSG 51 dendritic cell vaccines 51 allergen avoidance 51 dopamine neuron 51 Familial hypercholesterolemia 51 tumor histology 51 hippocampal function 51 HAR1 51 AKT1 mutation 51 Mass spectrometry 51 lipid mediators 51 functional dystrophin protein 51 elevated IOP 51 tau tangles 51 Dr. Ayalew Tefferi 51 MMP2 gene 51 cypin 51 leukocyte recruitment 51 Skeletal muscle 51 EML4 ALK 51 primate genomes 51 etiological factors 51 phenotypic traits 51 EGFR mutation status 51 metabolomic profiling 51 Hh 51 telogen effluvium 51 ERBB4 51 Accurately identifying 51 dietary interventions 51 cardiac fibrosis 51 infectious prion proteins 51 neuronal nicotinic receptors NNRs 51 autism susceptibility genes 51 Rebecca Garten 51 mitochondrial fusion 51 PDGF alpha receptor 51 miRagen 51 prognostic indicators 51 recombinant plasma 51 2DG 51 APOE genotype 51 theranostics 51 Lightlake 51 protein biochip 51 VersaFilm 51 neuropsychiatric disorders 51 pulmonary metastasis 51 Dr. Victor Velculescu 51 prognostically 51 Affinitak 51 SHANK3 gene 51 cardiometabolic disorders 51 Izpisúa Belmonte 51 RNA enzymes 51 #ß HSD1 51 pathogenetic mechanisms 51 molecular mechanisms underlying 51 XBP 1 51 antibiotic telavancin 51 Myc gene 51 myocyte 51 DARPP 51 ProNAi 51 TNF alpha inhibitor 51 SEPS1 51 kallikrein 51 multiprotein complex 51 MUC1 * 51 thymosin beta 4 51 Pericak Vance 51 cardio metabolic 51 Agilent microarray 51 Th2 immune 51 biodegradable nanoparticles 51 neuro imaging 51 Pim kinases 51 mitochondrial mutations 51 validated experimentally 51 Prof. Krainer 51 Ataluren 51 psychobiological 51 hedgehog signaling pathway 51 Mootha 51 meningeal 51 multi factorial diseases 51 Pepducin 51 TXNIP 51 EyeGate 51 postoperative atrial fibrillation 51 PI3 kinase inhibitors 51 predisposing factor 51 rheumatic disorders 51 ConclusionThis 51 miRNA expression 51 HH GLI 51 EGF receptor 51 PKC alpha 51 genome rearrangements 51 genotype phenotype 51 bicyclic 51 FGF signaling 51 glycan microarray 51 differential gene expression 51 Hox gene 51 B. Lynne Parshall 51 lipid synthesis 51 arterial thickening 51 amyloid deposition 51 autoantigen 51 C5aR 51 heritable diseases 51 humanized mouse 51 hematological indications 51 antiplatelet therapies 51 Prediman K. Shah 51 exon skipping 51 nosology 51 organogenesis 51 unicellular organism 51 malignant transformation 51 VHL gene 51 orofacial 51 Bone Biologics 51 excitotoxicity 51 staphylococcal infection 51 hypoxic tumors 51 NEUGENE R 51 Mice genetically engineered 51 Dr. Ruoslahti 51 tumor immunology 51 Zheng Cui 51 VASTox 51 Dr. Fehlings 51 vascular abnormalities 51 antiproliferative effects 51 genomic profiling 51 chronic obstructive airway 51 receptor subunits 51 tenascin C 51 TRP channels 51 haematological cancers 51 BBSRC funded 51 Robert Siliciano 51 genetic variants associated 51 Deinococcus 51 Hedgehog signaling 51 tRNA synthetases 51 pericytes 51 dendritic spine 51 proteomic technologies 51 causative mutations 51 Perceiva 51 Wnt signaling 50 myopathies 50 ligases 50 pharmacologic interventions 50 cellular pathways 50 synaptotagmin 50 noninvasive imaging 50 TFIIH 50 hematopoietic cells 50 GlgE 50 smooth muscle myosin 50 tenascin 50 GPR# [002] 50 exome sequencing 50 neuroinflammation 50 adipogenic 50 Prevagen 50 nonviral 50 mesenchymal stromal cells 50 insulin resistance syndrome 50 inherited predisposition 50 VCFS 50 transcutaneous immunization TCI 50 nonhuman primate model 50 therapeutic modality 50 allergic inflammation 50 Dr. Maraganore 50 LNPs 50 Joseph Loscalzo 50 GGF2 50 anatomical abnormalities 50 microbiome 50 etiologic 50 intestinal microbiota 50 catalytic antibodies 50 brainwave patterns 50 NEDD9 50 chromosome translocations 50 actin remodeling 50 spontaneous regression 50 Patricia Hartge 50 breast cancer metastasis 50 metabolic profiling 50 Ari Melnick 50 laterality 50 mRNA sequences 50 PIP3 50 neural crest 50 uPA 50 validate biomarkers 50 ductal adenocarcinoma 50 proteins misfold 50 neuro protective 50 proto oncogene 50 cartilage degeneration 50 chromosomal regions 50 metabolic abnormality 50 T2D 50 glial tumors 50 Sphingomab 50 intra abdominal abscess 50 poststroke depression 50 diseases Cerezyme 50 sphingolipid 50 mammary duct 50 autoimmune encephalitis 50 splice variants 50 zebrafish embryo 50 telomere dysfunction 50 #q# deletion 50 Difficulty swallowing 50 pharmacologic treatments 50 Alequel 50 serine proteases 50 autonomic dysfunction 50 tissue fibrosis 50 P#X# receptor 50 lung fibroblasts 50 EGF receptors 50 intracellular signaling 50 heritable disorders 50 coexpression 50 iniparib 50 bone morphogenetic proteins BMPs 50 H#K#me# 50 adenosine A2A receptor 50 artery stenosis 50 metabolic alterations 50 isoprenoid 50 telomerase enzyme 50 connexin 50 antiviral compounds 50 Alnylam RNAi 50 carbohydrate compounds 50 plasma proteome 50 modifier genes 50 Genome sequencing 50 sirtuin activators 50 Squalamine 50 gene polymorphisms 50 axonal regeneration 50 Dr. Kolls 50 MYH9 50 genetic polymorphism 50 fibrocytes 50 biopsychosocial model 50 p# MAPK 50 pharmacodynamic markers 50 phenotypic differences 50 cardiometabolic risk 50 focal segmental glomerulosclerosis FSGS 50 JAK STAT 50 genomic rearrangements 50 radionuclide therapy 50 Dr. Bert Vogelstein 50 p# pathway 50 Desmoteplase 50 Personalized medicine 50 Matchar 50 mesenchymal transition 50 telomere lengths 50 immunotherapeutic approaches 50 Pressure Cycling 50 Plasmodium parasite 50 Renata Pasqualini 50 FOXP2 gene 50 subcellular compartments 50 Evolutionarily speaking 50 glycan 50 physiologically relevant 50 endothelin receptor 50 myogenesis 50 previously undescribed 50 immuno modulatory 50 antioxidant supplementation 50 symptomology 50 stochastic resonance 50 neovascularization 50 sequence homology 50 sortilin 50 functional gastrointestinal disorders 50 autoinflammatory diseases 50 retinal degenerative disease 50 evolutionarily ancient 50 lymphatic vessel 50 biochemical imbalances 50 vertebrate evolution 50 tumor metastasis 50 sinonasal 50 VMAT2 50 ribonucleic acids 50 Nir Barzilai 50 immunosuppressive regimens 50 P#X# 50 Duchenne muscular dystrophy DMD 50 psoriatic 50 pegylated interferon lambda 50 Cognitive therapy 50 Anacetrapib 50 genomewide 50 phenotypic variation 50 structural rearrangements 50 neuronal signaling 50 cytochrome P# inhibition 50 multi celled organisms 50 allelic variation 50 maladaptive behaviors 50 CobaCyte 50 Newton Cheh 50 airway responsiveness 50 Sherine Gabriel 50 buccal delivery 50 habenula 50 CaM kinase 50 SELDI 50 lipodystrophy syndrome 50 RLY# 50 metabolic dysregulation 50 PKCi 50 molecular profiling 50 maturational 50 APOBEC 3G 50 psoriatic skin 50 epistasis 50 Alzheimer pathology 50 pharmacogenetics 49 EGFR TKI 49 molecular pathways 49 cancer chemoprevention 49 protein conformation 49 idiopathic pulmonary 49 Mark A. Sirgo 49 Wnt pathway 49 behavioral disinhibition 49 Pikaard 49 autoimmunity 49 Bryostatin 49 HDAC3 49 BCIs 49 #q#.# deletion syndrome 49 PsychoGenics 49 morphogen 49 Lenzenweger 49 aberrant activation 49 signaling cascades 49 Fikrig 49 metabolize cholesterol 49 mitral stenosis 49 previously uncharacterized 49 Novosom 49 Cyclin E 49 cellular senescence 49 Dr. Chenchen Wang 49 Polychronakos 49 meta cognitive 49 immunomodulation 49 Guillermo Torre Amione 49 bronchial epithelial cells 49 Pervasis 49 Protein folding 49 GIPET 49 colorectal tumor 49 prion gene 49 fibrogenesis 49 pharmacological therapies 49 neuronal degeneration 49 node metastasis 49 transcriptional regulation 49 gene expression microarray 49 pathophysiologic mechanisms 49 selective kinase inhibitors 49 ontogenetic 49 breast cancer susceptibility genes 49 pharmacological treatments 49 Molecular imaging 49 palladin 49 KineMed 49 MAP kinase pathway 49 obstructive coronary artery 49 developmental plasticity 49 Trophos 49 quantitate 49 embryological 49 xenobiotic 49 gastric cardia 49 histone code 49 filamentous fungi 49 optogenetics 49 Receptos 49 El Deiry 49 HLA genes 49 Shh signaling 49 OTCBB PWRM.OB 49 miR# 49 thrombosis blood clots 49 metabolomic 49 intercellular communication 49 ribonuclease 49 Edward Lanphier Sangamo 49 C1 INH deficiency 49 TRPV1 receptor 49 Evolutionary biologists 49 APOE ε4 49 epigenomic 49 EECP ® therapy 49 heterologous 49 underdiagnosis 49 Bardet Biedl Syndrome 49 axon guidance 49 RNA silencing 49 neuro developmental disorders 49 Juan Carlos Izpisúa Belmonte 49 dopamine D2 receptors 49 sphingolipids 49 Lung transplantation 49 PDGF CC 49 genomic discoveries 49 masculinization 49 BRCA testing 49 premenstrual syndrome PMS 49 metaanalysis 49 c myc gene 49 chromosome condensation 49 metazoans 49 cartilage regeneration 49 Dr. Masashi Yanagisawa 49 genetic polymorphisms 49 proliferative disorders 49 treat premature ejaculation 49 aneuploid 49 PECAM 1 49 Eunyoung Cho 49 histone deacetylase 49 ASPIRE HIGHER 49 optogenetic 49 nutlin 49 epigenetic inheritance 49 tumor microenvironment 49 therapeutically useful 49 Histone deacetylase 49 TGF ß1 49 zebrafish Danio rerio 49 glycobiology 49 Aquinox 49 Incretin mimetics 49 serum urate levels 49 serine protease 49 FMRP protein 49 urinary calculi 49 vivo molecular imaging 49 MAP kinase 49 genomic instability 49 venous malformations 49 allosteric modulation 49 GPR# receptor [002] 49 Fluorescence microscopy 49 extracranial veins 49 Catabasis 49 bacterial antibiotic resistance 49 pre mRNA splicing 49 liquid crystalline 49 hereditary predisposition 49 chromosome rearrangements 49 methanogenesis 49 POC diagnostics 49 chromatin modification 49 neural tissues 49 epigenome 49 Schwann cell 49 sd rxRNA 49 proteomic analysis 49 pharmacological therapy 49 hammerhead ribozyme 49 causal pathways 49 oxidative stress induction 49 Mechanistically 49 clonal expansion 49 regenerative therapy 49 drug metabolizing enzymes 49 antiangiogenic